Logo

GPAT

GP-Act III Acquisition Corp.

GPAT

GP-Act III Acquisition Corp. • NASDAQ
$10.65 ▼ -0.05% (-0.01)
Market Cap $382.73 M
52w High $10.72
52w Low $10.12
Dividend Yield 0%
P/E 31.32
Volume 915
Outstanding Shares 35.94M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $0 $126.328K ▼ $3.106M ▲ 0% $0.09 ▲ $0 ▲
Q2-2025 $0 $141.334K ▼ $2.985M ▲ 0% $0.083 ▲ $-141.334K ▲
Q1-2025 $0 $200.052K ▲ $2.907M ▼ 0% $0.081 ▼ $-200K ▼
Q4-2024 $0 $184.359K ▲ $3.304M ▼ 0% $0.092 ▼ $-184K ▼
Q3-2024 $0 $143.462K $3.656M 0% $0.1 $-143K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $145.453K ▼ $306.496M ▲ $14.694M ▼ $-14.4M ▼
Q2-2025 $246.314K ▼ $303.424M ▲ $14.727M ▼ $288.697M ▲
Q1-2025 $376.572K ▼ $300.488M ▲ $14.776M ▲ $285.712M ▲
Q4-2024 $483.572K ▼ $297.474M ▲ $14.669M ▲ $282.805M ▲
Q3-2024 $513.507K $294.097M $14.596M $279.5M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $3.106M ▲ $-100.861K ▲ $0 $0 $-100.861K ▲ $-100.861K ▲
Q2-2025 $2.985M ▲ $-130.258K ▲ $0 $0 ▼ $-130.258K ▼ $-130.258K ▲
Q1-2025 $2.907M ▼ $-151.938K ▼ $0 $44.938K ▲ $-107K ▼ $-151.938K ▼
Q4-2024 $3.304M ▼ $-29.935K ▲ $0 $0 $-29.935K ▲ $-29.935K ▲
Q3-2024 $3.656M $-58.258K $0 $0 $-58.258K $-58.258K

Five-Year Company Overview

Income Statement

Income Statement GP-Act III Acquisition Corp. is a typical pre-deal SPAC, so its income statement is very simple. It has no operating revenue because it doesn’t run a normal business yet; it mainly holds investor cash and earns small amounts of income from that. Recent results show a tiny profit, driven by financial and one-off items rather than ongoing operations. In practical terms, there is no real track record of sales, margins, or business performance to evaluate—future financials will depend almost entirely on whichever company it chooses to merge with.

Balance Sheet

Balance Sheet The balance sheet reflects a newly formed cash shell. Most of the value sits in financial assets linked to the funds raised in its IPO, with essentially no traditional operating assets like factories, inventory, or receivables. There is no meaningful debt shown, and equity represents the capital provided by shareholders and sponsors. Overall, this is a clean, simple balance sheet typical of a SPAC: mostly cash-like assets, minimal liabilities, and no operating infrastructure until a merger is completed.

Cash Flow

Cash Flow Cash flows are minimal and largely administrative at this stage. There is no operating cash inflow from customers, and spending mainly relates to public company costs and deal-search activities, funded by the IPO proceeds and sponsor capital. Because the trust cash is usually restricted for the eventual transaction or redemptions, day-to-day cash usage tends to be tightly controlled. True operating and investment cash flow patterns will only emerge after a merger, when an underlying business is in place.

Competitive Edge

Competitive Edge As a SPAC, GP-Act III’s competitive position is not about products or market share, but about its ability to source and negotiate an attractive deal. Its “edge” comes from its management team, their network, and their judgment in selecting a target. The SPAC market is crowded, and many vehicles chase a limited pool of desirable private companies, so competition for strong targets can be intense. Until a merger partner is announced, it is not possible to assess the long-term competitive position, because that will depend on the quality and industry of the acquired company.

Innovation and R&D

Innovation and R&D GP-Act III does not conduct traditional innovation or R&D—it is a financial vehicle, not an operating company. Any future innovation exposure will come entirely from the business it chooses to merge with. Management has signaled interest in high-potential U.S. companies, and their background suggests they may lean toward consumer or related areas, but they are not constrained to a single sector. Meaningful analysis of technology, product pipelines, or research intensity will only be possible once a specific target is identified and detailed disclosures are available.

Summary

GP-Act III Acquisition Corp. is best viewed as a pool of capital with a mandate to find and merge with an operating business, rather than as a traditional company with its own revenue, products, and strategy. Its current financials largely reflect cash raised, a clean balance sheet, very limited expenses, and no operating history. The key drivers from here are purely forward-looking: which company it selects, the terms of that deal, the quality and growth prospects of the target, and how well the combined entity can compete in its chosen industry. Until a merger is announced and detailed information about the target is released, any assessment of long-term earnings power, competitive strength, or innovation remains highly uncertain and speculative.